| Zane Andrews |
Monash University |
| Manu Chakravarthy |
Carmot/Roche |
| Paul Cohen |
The Rockefeller University |
| Silvia Corvera |
University of Massachusetts Medical School |
| Michael Czech |
University of Massachusetts Medical School |
| Joel Elmquist |
University of Texas, Southwestern |
| Mark Febbraio |
Monash University |
| Johan Fernø |
University of Bergen |
| Zach Gerhart-Hines |
University of Copenhagen |
| Lora Heisler |
University of Aberdeen |
| Andrea Hevener |
University of California |
| Marie Holt |
University of Warwick |
| David Hornigold |
AstraZeneca |
| David James |
University of Sydney |
| Lawrence Kazak |
McGill University |
| Deborah Muoio |
Duke Molecular Physiology Institute |
| Søren Nielsen |
University Hospital of Copenhagen |
| Kirsten Raun |
Novo Nordisk |
| Eric Ravussin |
Pennington Biomedical Research Center |
| Evan Rosen |
Harvard University |
| Camilla Scheele |
CBMR, University of Copenhagen |
| Phil Scherer |
UT Southwestern |
| Mark Sleeman |
Regeneron Pharmaceuticals, Inc. |
| Kirsty Spalding |
Karolinska Institutet |
| Greg Steinberg |
McMaster University |
| Tony Tiganis |
Monash University |
| James Trevaskis |
Eli Lilly |
| Matthias Tschöp |
Helmholtz Zentrum München |
| Murielle Veniant-Ellison |
AMGEN |
| Christian Wolfrum |
ETH Zurich |
| Giles Yeo |
University of Cambridge |
| Jeffrey Zigman |
University of Texas, Southwestern |
